Alpa Labs 38th AGM: All 7 resolutions passed with over 99% majority
ALPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.4 pts more than Nifty Microcap 250 and 6.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Alpa Laboratories' 38th AGM held on Sept 30, 2026 via video conferencing. All 7 resolutions passed with requisite majority. 49 shareholders holding 1.21 crore shares voted. Key items approved: audited standalone and consolidated financial statements (over 99.93% in favor), re-appointment of Mr. Mahendra Singh Chawla as director, ratification of cost auditors, appointment of Mrs. Radhika Biyani as Independent Director for 5 years, approval for loans and investments up to Rs. 160 crores, and re-appointment of Mr. Paresh Chawla as Managing Director for 5 years.
Strong shareholder backing for all resolutions. MD re-appointment confirmed and Rs. 160 crore investment cap approved, giving management flexibility.